Followers | 644 |
Posts | 38176 |
Boards Moderated | 1 |
Alias Born | 03/29/2003 |
Wednesday, November 22, 2017 1:07:33 AM
"Increase in 2nd Institutional Financing Agreement to $7 Million. Since December 30, 2016 we have received $3.35 million in financing from KAYS’ institutional investor through the offer and sale of convertible promissory notes under a $2.1 million financing agreement completed in early 2017 and an additional $7.0 million financing agreement (increased from $5.8 million) originally entered into in May 2011. In addition to $2.1mm under the initial agreement, we have received $1.15 mm under the second agreement and are scheduled to receive an additional $5.85 million under the second agreement over the next 2 years (subject to market conditions and other factors)."
*Expenses are quadrupling Revenues?
Recent KAYS News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/15/2024 09:38:31 PM
- Investor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health • InvestorsHub NewsWire • 11/28/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:25:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 01:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:15:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 11:48:09 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:15:57 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 12:44:25 PM
- Kaya Holdings, Inc.'s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A. • InvestorsHub NewsWire • 05/24/2023 01:48:14 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM